NASDAQ: CGTX - Cognition Therapeutics, Inc.

Lønnsomhet i seks måneder: -53.85%
Sektor: Healthcare

Kampanjeplan Cognition Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex for the treatment of Alzheimer's disease.

flere detaljer
The company is also developing COG0201 SHINE, a randomized double-blind and placebo-controlled for mild-to-moderate AD and is in phase II clinical trial. Its product pipeline also includes CT2168 for Synucleinopathies; and CT2074 for dry age-related macular degeneration. The company was incorporated in 2007 and is headquartered in Purchase, New York.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-10-08
ISIN US19243B1026
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.cogrx.com
Цена ао 1.83
Prisendring per dag: +9.46% (0.7674)
Prisendring per uke: +33.31% (0.6301)
Prisendring per måned: +111.11% (0.3979)
Prisendring over 3 måneder: +99.62% (0.4208)
Prisendring over seks måneder: -53.85% (1.82)
Prisendring per år: -54.59% (1.85)
Prisendring over 3 år: -83.53% (5.1)
Prisendring over 5 år: 0% (0.84)
Prisendring over 10 år: 0% (0.84)
Prisendring siden begynnelsen av året: +111.11% (0.3979)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 2.16 7
P/E 0 0
EV/EBITDA -0.4577 0
Total: 3.38

Effektivitet

Navn Betydning Karakter
ROA, % -73.34 0
ROE, % -105.37 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0034 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 628.83 10
Lønnsomhet EPS, % 163.99 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Pathstone Holdings, LLC 2205377 5.65
AIGH Capital Management LLC 2038853 5.23
Vanguard Group Inc 721554 1.85
Worth Venture Partners, LLC 508719 1.3
Carlson Capital. L.P. 238000 0.61
Kestra Advisory Services, LLC 219434 0.56
American Financial Group Inc. 205000 0.53
Geode Capital Management, LLC 174798 0.45
Mercer Global Advisors, Inc./ADV 130951 0.34
Commonwealth Equity Services, LLC 92730 0.24

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00461 17.09 1.54048



Veileder Stillingstittel Betaling Fødselsår
Ms. Lisa Ricciardi CEO, President & Director 854.15k 1960 (65 år)
Dr. Anthony O. Caggiano M.D., Ph.D. Chief Medical Officer and Head of R&D 616.27k 1970 (55 år)
Mr. John Brendan Doyle Chief Financial Officer 414.88k 1977 (48 år)
Dr. Steven A. Weissman Ph.D. VP & Head of CMC N/A
Ms. Anita Cornet Head of Quality
Mr. Bobby Horn Corporate Controller

Adresse: United States, Purchase. NY, 2500 Westchester Avenue - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.cogrx.com